What is this?

HISWAI shows you what’s connected to topics that interest you, and where to find more. HISWAI members can curate information with dashboards to gain insights, proper context and stay up to date on the latest relevant information. Sharing these discoveries with others is easy too!

help

Want to know more?

Tag: Human orthopneumovirus

Tag Visualization: Top 50 related tags by occurrence

Recent Articles

Promising RSV Vaccine Candidate Raises Hopes - Pharmacy Times
Check Sources

2023-01-02 22:53:07

Medical specialties
Medicine
Microbiology
RTT
Human orthopneumovirus
Paramyxoviridae
Vaccination
Vaccine
Common cold
Influenza
Influenza vaccine
hVIVO signs £5.2m contract with a global biotechnology company - DirectorsTalk Interviews
Check Sources

2023-01-04 07:54:15

Human orthopneumovirus
Paramyxoviridae
Nucleolin
RSV
Open Orphan plc
hVIVO plc
FDA accepts application for nirsevimab against RSV in infants - Contemporary Pediatrics
Check Sources

2023-01-05 19:22:43

Companies
Life Sciences
AstraZeneca
Articles
Monoclonal antibodies
Biotechnology
Palivizumab
Human orthopneumovirus
RSV
Sanofi
FDA to review preventative option for RSV in infants, developers say | Health - WKTV
Check Sources

2023-01-05 16:39:46

AstraZeneca
Human orthopneumovirus
Paramyxoviridae
Companies
Life Sciences
RSV
Articles
Nucleolin
Pediatrics
Palivizumab
Motavizumab
USFDA accepts AstraZeneca's BLA for nirsevimab to prevent RSV lower respiratory tract disease
Check Sources

2023-01-06 09:30:34

AstraZeneca
Monoclonal antibodies
Biotechnology
Palivizumab
Life Sciences
Human orthopneumovirus
Companies
Articles
RSV
Nucleolin
Lower respiratory
Sanofi
COVID-19, Affordable Housing Among Top 10 CNC stories in 2022 | News
Check Sources

2023-01-06 20:16:42

Drugs
Organic compounds
Opioids
RTT
Influenza
Anilides
Euphoriants
Janssen Pharmaceutica
Naloxone
Fentanyl
Human orthopneumovirus
SAN DIEGO
FDA Set To Fast-Track New Drug To Prevent Infant RSV - Health Digest
Check Sources

2023-01-07 10:02:34

Respiratory diseases
Medical specialties
Medicine
Human orthopneumovirus
Paramyxoviridae
RTT
Common cold
RSV
Pneumonia
Nucleolin
Cough
Orthopneumovirus
Why The Moderna Stock Increased 3.94% (MRNA)
Check Sources

2023-01-08 18:28:46

Branches of biology
Biology
Life Sciences
Human orthopneumovirus
Paramyxoviridae
RSV
Moderna
Messenger RNA
Traders Purchase High Volume of Call Options on Novavax (NASDAQ:NVAX) - MarketBeat
Check Sources

2023-01-09 18:29:56

Economy
Finance
Money
Novavax
Stock market
Financial regulation
Short
Financial analyst
Securities research
Stock
Price?earnings ratio
Human orthopneumovirus
Novavax Inc.
Is cold and flu season really worse this year? - The Toronto Star
Check Sources

2023-01-22 22:31:55

Medical specialties
Medicine
Immunology
Health
Influenza
RTT
Virus
Human orthopneumovirus
Flu pandemic
Flu season
Immune system
Immunity